Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Inotiv, Inc
483
•Inotiv, Inc•October 24, 2025

Inotiv, Inc – FDA 483, Oct 24, 2025

Record Details

During an inspection conducted by the U.S. Food and Drug Administration (FDA) from October 20-24, 2025, at Inotiv, Inc.'s Biopharmaceutics Analytical Facility & Nonclinical Laboratory in West Lafayette, IN, several regulatory observations were noted in an FDA Form 483. The inspection highlighted deficiencies primarily related to analytical method validation for insulin aspart.

Specifically, the company failed to properly evaluate the effect of lipemia for selectivity and matrix effect experiments during the validation of insulin aspart in human serum, using plasma instead of serum. Furthermore, whole blood stability of insulin aspart was not assessed during method validation; short-term stability testing was also conducted using plasma. A third significant observation detailed that source records for various method validation experiments, including long-term stability, dilution integrity, stability in matrix, and ion suppression, did not adequately document the use of lithium heparinized human lysed whole blood as the matrix, despite its utilization in actual study samples.

These inspectional observations indicate deviations from expected laboratory practices for analytical method validation. Inotiv, Inc. is required to address these findings and implement appropriate corrective actions to ensure the integrity and reliability of their analytical data and processes.

Company
Inotiv, Inc
Inspection date
October 24, 2025
Product type
drugs
Office
Detroit District Office
People
  • Sripal Reddy Mada (investigator)
  • Barbara D. Wright (investigator)
View Company Profile

ID · 19f9e4e6-5159-4a72-8071-61aa67df48b5

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Inotiv, Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.